RxDoctor Payments Data

Ruben Rivera Rivera, MD

Sports Medicine · Clermont, FLNPI 1639565955

Payments from drug & device makers

$2,132in general payments, 2019–2025

Across 53 payments — averaging $40.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Painteq LLC$775
  • Boston Scientific$502
  • Abbott$306
  • Scilex Pharmaceuticals Inc.$140
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$97
  • AbbVie$60
  • plus $252 from 7 others

What the payments were for

  • Travel & lodging$965%
  • Food & beverage$1,58975%
  • Education$44721%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,132 in reported general payments places this provider in the 50th percentile of 402 sports medicine providers in Florida.

See all sports medicine providers in Florida

Medicare billing

Part B allowed, 2024
$205,111
Medicare patients
441
Services billed
1,917

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen524$18,691
Xtampza ErOxycodone Myristate35$15,252
OxycontinOxycodone Hcl26$15,066
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen617$15,034
Oxycodone Hcl277$6,324
Pregabalin320$5,973
Lidocaine47$5,117
Morphine Sulfate ErMorphine Sulfate169$4,673
Gabapentin318$4,635
Tramadol Hcl327$2,833
Celecoxib57$2,476
Fentanyl21$2,272
Buprenorphine12$1,786
Tizanidine Hcl162$1,696
Methocarbamol124$1,194

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$58$15,25235 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 402 sports medicine providers in Florida.

Other sports medicine in Clermont

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →